ID   FRIH_HUMAN              Reviewed;         183 AA.
AC   P02794; B3KNR5; Q3KRA8; Q3SWW1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   18-JUN-2025, entry version 260.
DE   RecName: Full=Ferritin heavy chain;
DE            Short=Ferritin H subunit;
DE            EC=1.16.3.1 {ECO:0000269|PubMed:9003196};
DE   AltName: Full=Cell proliferation-inducing gene 15 protein;
DE   Contains:
DE     RecName: Full=Ferritin heavy chain, N-terminally processed;
GN   Name=FTH1; Synonyms=FTH, FTHL6; ORFNames=OK/SW-cl.84, PIG15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hepatocyte;
RX   PubMed=6323167; DOI=10.1002/j.1460-2075.1984.tb01756.x;
RA   Costanzo F., Santoro C., Colantuoni V., Bensi G., Raugei G., Romano V.,
RA   Cortese R.;
RT   "Cloning and sequencing of a full length cDNA coding for a human
RT   apoferritin H chain: evidence for a multigene family.";
RL   EMBO J. 3:23-27(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3840162; DOI=10.1016/s0021-9258(17)39094-4;
RA   Boyd D., Vecoli C., Belcher D.M., Jain S.K., Drysdale J.W.;
RT   "Structural and functional relationships of human ferritin H and L chains
RT   deduced from cDNA clones.";
RL   J. Biol. Chem. 260:11755-11761(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3023856; DOI=10.1128/mcb.6.2.566-573.1986;
RA   Chou C.-C., Gatti R.A., Fuller M.L., Concannon P., Wong A., Chada S.,
RA   Davis R.C., Salser W.A.;
RT   "Structure and expression of ferritin genes in a human promyelocytic cell
RT   line that differentiates in vitro.";
RL   Mol. Cell. Biol. 6:566-573(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3003694; DOI=10.1093/nar/14.2.721;
RA   Costanzo F., Colombo M., Staempfli S., Santoro C., Marone M., Frank R.,
RA   Delius H., Cortese R.;
RT   "Structure of gene and pseudogenes of human apoferritin H.";
RL   Nucleic Acids Res. 14:721-736(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3020541; DOI=10.1073/pnas.83.19.7226;
RA   Hentze M.W., Keim S., Papadopoulos P., O'Brien S., Modi W., Drysdale J.W.,
RA   Leonard W.J., Harford J.B., Klausner R.D.;
RT   "Cloning, characterization, expression, and chromosomal localization of a
RT   human ferritin heavy-chain gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7226-7230(1986).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7916709; DOI=10.1016/0378-1119(93)90380-l;
RA   Dhar M., Chauthaiwale V.M., Joshi J.G.;
RT   "Sequence of a cDNA encoding the ferritin H-chain from an 11-week-old human
RT   fetal brain.";
RL   Gene 126:275-278(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Chauthaiwale V.M., Dhar M., McLachlan D.R., Joshi J.G.;
RT   "Cloning of a novel full length cDNA for ferritin heavy chain from normal
RT   adult human and Alzheimer's brain.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Franco A.V., Gray C.P., Myers K., Hersey P.;
RT   "Detection of ferritin heavy chain by SEREX: a multifunctional molecule in
RT   malignant tumour cells.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a human cell proliferation gene 15.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-reactive
RT   CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Cervix, Colon, Lung, Ovary, Prostate, and Salivary
RC   gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 128-183.
RX   PubMed=6589621; DOI=10.1073/pnas.81.15.4751;
RA   Boyd D., Jain S.K., Crampton J., Barrett K.J., Drysdale J.;
RT   "Isolation and characterization of a cDNA clone for human ferritin heavy
RT   chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4751-4755(1984).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLU-28; LYS-87 AND
RP   GLU-108.
RX   PubMed=9003196; DOI=10.1021/bi961830l;
RA   Treffry A., Zhao Z., Quail M.A., Guest J.R., Harrison P.M.;
RT   "Dinuclear center of ferritin: studies of iron binding and oxidation show
RT   differences in the two iron sites.";
RL   Biochemistry 36:432-441(1997).
RN   [17]
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN HFE5.
RX   PubMed=11389486; DOI=10.1086/321261;
RA   Kato J., Fujikawa K., Kanda M., Fukuda N., Sasaki K., Takayama T.,
RA   Kobune M., Takada K., Takimoto R., Hamada H., Ikeda T., Niitsu Y.;
RT   "A mutation, in the iron-responsive element of H ferritin mRNA, causing
RT   autosomal dominant iron overload.";
RL   Am. J. Hum. Genet. 69:191-197(2001).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179 AND SER-183, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   FUNCTION, INTERACTION WITH NCOA4, AND SUBCELLULAR LOCATION.
RX   PubMed=24695223; DOI=10.1038/nature13148;
RA   Mancias J.D., Wang X., Gygi S.P., Harper J.W., Kimmelman A.C.;
RT   "Quantitative proteomics identifies NCOA4 as the cargo receptor mediating
RT   ferritinophagy.";
RL   Nature 509:105-109(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ARG-23.
RX   PubMed=26436293; DOI=10.7554/elife.10308;
RA   Mancias J.D., Pontano Vaites L., Nissim S., Biancur D.E., Kim A.J.,
RA   Wang X., Liu Y., Goessling W., Kimmelman A.C., Harper J.W.;
RT   "Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated
RT   by iron dependent HERC2-mediated proteolysis.";
RL   Elife 4:0-0(2015).
RN   [29]
RP   INVOLVEMENT IN NBIA9.
RX   PubMed=37660254; DOI=10.1016/j.xhgg.2023.100236;
RA   Shieh J.T., Tintos-Hernandez J.A., Murali C.N., Penon-Portmann M.,
RA   Flores-Mendez M., Santana A., Bulos J.A., Du K., Dupuis L., Damseh N.,
RA   Mendoza-Londono R., Berera C., Lee J.C., Phillips J.J., Alves C.A.P.F.,
RA   Dmochowski I.J., Ortiz-Gonzalez X.R.;
RT   "Heterozygous Nonsense Variants in the Ferritin Heavy Chain Gene FTH1 Cause
RT   a Neuroferritinopathy.";
RL   HGG Adv. 4:100236-100236(2023).
RN   [30] {ECO:0007744|PDB:1FHA}
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH IRON.
RX   PubMed=1992356; DOI=10.1038/349541a0;
RA   Lawson D.M., Artymiuk P.J., Yewdall S.J., Smith J.M.A., Livingstone J.C.,
RA   Treffry A., Luzzago A., Levi S., Arosio P., Cesarini G., Thomas C.D.,
RA   Shaw W.V., Harrison P.M.;
RT   "Solving the structure of human H ferritin by genetically engineering
RT   intermolecular crystal contacts.";
RL   Nature 349:541-544(1991).
RN   [31] {ECO:0007744|PDB:2FHA}
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), AND SUBUNIT.
RX   PubMed=9159481; DOI=10.1006/jmbi.1997.0970;
RA   Hempstead P.D., Yewdall S.J., Fernie A.R., Lawson D.M., Artymiuk P.J.,
RA   Rice D.W., Ford G.C., Harrison P.M.;
RT   "Comparison of the three-dimensional structures of recombinant human H and
RT   horse L ferritins at high resolution.";
RL   J. Mol. Biol. 268:424-448(1997).
CC   -!- FUNCTION: Stores iron in a soluble, non-toxic, readily available form.
CC       Important for iron homeostasis. Has ferroxidase activity
CC       (PubMed:9003196). Iron is taken up in the ferrous form and deposited as
CC       ferric hydroxides after oxidation (PubMed:9003196). Also plays a role
CC       in delivery of iron to cells (By similarity). Mediates iron uptake in
CC       capsule cells of the developing kidney (By similarity). Delivery to
CC       lysosomes is mediated by the cargo receptor NCOA4 for autophagic
CC       degradation and release of iron (PubMed:24695223, PubMed:26436293).
CC       {ECO:0000250|UniProtKB:P09528, ECO:0000269|PubMed:24695223,
CC       ECO:0000269|PubMed:26436293, ECO:0000269|PubMed:9003196}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4 Fe(2+) + O2 + 4 H(+) = 4 Fe(3+) + 2 H2O;
CC         Xref=Rhea:RHEA:11148, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034; EC=1.16.3.1;
CC         Evidence={ECO:0000269|PubMed:9003196};
CC   -!- SUBUNIT: Oligomer of 24 subunits (PubMed:9159481). There are two types
CC       of subunits: L (light) chain and H (heavy) chain (PubMed:9159481). The
CC       major chain can be light or heavy, depending on the species and tissue
CC       type. In the human liver, the heavy chain is predominant
CC       (PubMed:9159481). The functional molecule forms a roughly spherical
CC       shell with a diameter of 12 nm and contains a central cavity into which
CC       the insoluble mineral iron core is deposited (PubMed:9159481).
CC       Interacts with NCOA4; NCOA4 promotes targeting of the iron-binding
CC       ferritin complex to autolysosomes following starvation or iron
CC       depletion (PubMed:24695223). {ECO:0000269|PubMed:24695223,
CC       ECO:0000269|PubMed:9159481}.
CC   -!- INTERACTION:
CC       P02794; O95429: BAG4; NbExp=4; IntAct=EBI-713259, EBI-2949658;
CC       P02794; Q9UER7: DAXX; NbExp=5; IntAct=EBI-713259, EBI-77321;
CC       P02794; P02794: FTH1; NbExp=3; IntAct=EBI-713259, EBI-713259;
CC       P02794; P02792: FTL; NbExp=19; IntAct=EBI-713259, EBI-713279;
CC       P02794; P51116: FXR2; NbExp=3; IntAct=EBI-713259, EBI-740459;
CC       P02794; P04792: HSPB1; NbExp=2; IntAct=EBI-713259, EBI-352682;
CC       P02794; P61244: MAX; NbExp=2; IntAct=EBI-713259, EBI-751711;
CC       P02794; P02786: TFRC; NbExp=2; IntAct=EBI-713259, EBI-355727;
CC       P02794; Q92574: TSC1; NbExp=3; IntAct=EBI-713259, EBI-1047085;
CC       P02794; Q2Q067: HBZ; Xeno; NbExp=3; IntAct=EBI-713259, EBI-9675545;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26436293}. Lysosome
CC       {ECO:0000269|PubMed:26436293}. Cytoplasmic vesicle, autophagosome
CC       {ECO:0000269|PubMed:24695223}.
CC   -!- TISSUE SPECIFICITY: Expressed in the liver.
CC       {ECO:0000269|PubMed:11389486}.
CC   -!- DISEASE: Hemochromatosis 5 (HFE5) [MIM:615517]: A disorder of iron
CC       metabolism characterized by iron overload. Excess iron is deposited in
CC       a variety of organs leading to their failure, and resulting in serious
CC       illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy,
CC       arthritis, and hypogonadotropic hypogonadism. Severe effects of the
CC       disease usually do not appear until after decades of progressive iron
CC       loading. {ECO:0000269|PubMed:11389486}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry. In a Japanese
CC       family affected by HFE5, a single point mutation has been detected in
CC       the iron-responsive element (IRE) in the 5'-UTR of FTH1 mRNA. This
CC       mutation leads to an increased binding affinity for iron regulatory
CC       protein and thereby to the efficient suppression of mRNA translation.
CC   -!- DISEASE: Neurodegeneration with brain iron accumulation 9 (NBIA9)
CC       [MIM:620669]: An autosomal dominant neurodegenerative disorder
CC       associated with iron accumulation, primarily in the basal ganglia. It
CC       is characterized by global developmental delay apparent from infancy,
CC       and progressive decline of motor and cognitive skills. Clinical
CC       features include delayed walking or inability to walk, spasticity with
CC       hyperreflexia, ataxia, dystonia, and poor or absent language.
CC       {ECO:0000269|PubMed:37660254}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ferritin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI05803.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ferritin entry;
CC       URL="https://en.wikipedia.org/wiki/Ferritin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00318; CAA25086.1; -; mRNA.
DR   EMBL; M11146; AAA52437.1; -; mRNA.
DR   EMBL; M12937; AAA35830.1; -; mRNA.
DR   EMBL; X03487; CAA27205.1; -; Genomic_DNA.
DR   EMBL; X03488; CAA27205.1; JOINED; Genomic_DNA.
DR   EMBL; M14212; AAA52438.1; -; Genomic_DNA.
DR   EMBL; M14211; AAA52438.1; JOINED; Genomic_DNA.
DR   EMBL; M97164; AAA35832.1; -; mRNA.
DR   EMBL; L20941; AAA35833.1; -; mRNA.
DR   EMBL; AF088851; AAF89523.1; -; mRNA.
DR   EMBL; AY258285; AAP82230.1; -; mRNA.
DR   EMBL; AB062402; BAB93489.1; -; mRNA.
DR   EMBL; AK054816; BAG51427.1; -; mRNA.
DR   EMBL; DQ496108; ABF47097.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW73989.1; -; Genomic_DNA.
DR   EMBL; BC000857; AAH00857.1; -; mRNA.
DR   EMBL; BC001399; AAH01399.1; -; mRNA.
DR   EMBL; BC011359; AAH11359.1; -; mRNA.
DR   EMBL; BC013724; AAH13724.1; -; mRNA.
DR   EMBL; BC015156; AAH15156.1; -; mRNA.
DR   EMBL; BC016009; AAH16009.1; -; mRNA.
DR   EMBL; BC016857; AAH16857.1; -; mRNA.
DR   EMBL; BC063514; AAH63514.1; -; mRNA.
DR   EMBL; BC066961; AAH66961.1; -; mRNA.
DR   EMBL; BC073750; AAH73750.1; -; mRNA.
DR   EMBL; BC104643; AAI04644.1; -; mRNA.
DR   EMBL; BC105802; AAI05803.1; ALT_INIT; mRNA.
DR   EMBL; M15383; AAA52479.1; -; mRNA.
DR   CCDS; CCDS41655.1; -.
DR   PIR; A23517; FRHUH.
DR   RefSeq; NP_002023.2; NM_002032.3.
DR   PDB; 1FHA; X-ray; 2.40 A; A=1-183.
DR   PDB; 2CEI; X-ray; 1.80 A; A=2-183.
DR   PDB; 2CHI; X-ray; 1.60 A; A=2-183.
DR   PDB; 2CIH; X-ray; 1.50 A; A=2-183.
DR   PDB; 2CLU; X-ray; 2.10 A; A=2-183.
DR   PDB; 2CN6; X-ray; 2.20 A; A=2-183.
DR   PDB; 2CN7; X-ray; 1.75 A; A=2-183.
DR   PDB; 2FHA; X-ray; 1.90 A; A=1-183.
DR   PDB; 2IU2; X-ray; 1.80 A; A=2-183.
DR   PDB; 2Z6M; X-ray; 2.72 A; A/B/C/D/E/F/G/H/I/J/K/L=2-177.
DR   PDB; 3AJO; X-ray; 1.52 A; A=2-183.
DR   PDB; 3AJP; X-ray; 1.90 A; A=2-183.
DR   PDB; 3AJQ; X-ray; 1.58 A; A=2-183.
DR   PDB; 3ERZ; X-ray; 3.06 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 3ES3; X-ray; 2.79 A; A=1-183.
DR   PDB; 4DYX; X-ray; 1.85 A; A=6-177.
DR   PDB; 4DYY; X-ray; 1.90 A; A=6-177.
DR   PDB; 4DYZ; X-ray; 2.30 A; A=6-177.
DR   PDB; 4DZ0; X-ray; 2.50 A; A=6-177.
DR   PDB; 4OYN; X-ray; 1.43 A; A=1-183.
DR   PDB; 4Y08; X-ray; 1.34 A; A=1-183.
DR   PDB; 4YKH; X-ray; 1.52 A; A=1-183.
DR   PDB; 4ZJK; X-ray; 1.56 A; A=2-183.
DR   PDB; 5CMQ; X-ray; 1.94 A; A=2-183.
DR   PDB; 5CMR; X-ray; 3.79 A; A=2-183.
DR   PDB; 5GN8; X-ray; 2.81 A; A=2-183, B=2-153.
DR   PDB; 5GOU; X-ray; 2.91 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=1-183.
DR   PDB; 5JKK; X-ray; 1.60 A; A/B/C/D/E/F/G/H=1-183.
DR   PDB; 5JKL; X-ray; 1.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 5JKM; X-ray; 1.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 5N26; X-ray; 2.05 A; A=2-183.
DR   PDB; 5N27; X-ray; 1.74 A; A=2-183.
DR   PDB; 5UP7; X-ray; 1.79 A; A=2-183.
DR   PDB; 5UP8; X-ray; 2.63 A; A=2-183.
DR   PDB; 5UP9; X-ray; 2.45 A; A/B/C/D/E/F=2-183.
DR   PDB; 5VTD; X-ray; 1.95 A; A=2-183.
DR   PDB; 5XB1; EM; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-160.
DR   PDB; 5YI5; EM; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-177.
DR   PDB; 5ZND; X-ray; 3.00 A; A=1-134.
DR   PDB; 6B8F; X-ray; 1.06 A; A=2-183.
DR   PDB; 6B8G; X-ray; 1.13 A; A=2-183.
DR   PDB; 6FTV; X-ray; 1.58 A; A=2-183.
DR   PDB; 6GSR; EM; 5.50 A; Aa/Ac/Ad/Ae/Af/Ag/Ah/Ai/Aj/Ak/Al/Am/An/Ao/Ap/Ar/As/At/Au/Av/Aw/Ax/Ay/Az=2-183.
DR   PDB; 6H5I; EM; 3.90 A; Aa/Ac/Ad/Ae/Af/Ag/Ah/Ai/Aj/Ak/Al/Am/An/Ao/Ap/Ar/As/At/Au/Av/Aw/Ax/Ay/Az=6-177.
DR   PDB; 6H6T; X-ray; 1.90 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 6H6U; X-ray; 2.00 A; A/B/C/D/E/F=1-183.
DR   PDB; 6IPC; X-ray; 4.44 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=2-183.
DR   PDB; 6IPO; X-ray; 3.00 A; A/B=2-183.
DR   PDB; 6IPP; X-ray; 2.70 A; A/B=2-183.
DR   PDB; 6IPQ; X-ray; 3.10 A; A=2-183.
DR   PDB; 6J4A; X-ray; 3.99 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 6J7G; X-ray; 3.87 A; A/B/C/D/G/H/I/J/M/N/O/P/Q/R/S/T/W/X/Y/Z/a/b/e/f=2-183.
DR   PDB; 6JOB; Other; 2.93 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 6JPS; X-ray; 3.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=2-183.
DR   PDB; 6KE2; X-ray; 1.80 A; A=1-183.
DR   PDB; 6KE4; X-ray; 2.30 A; A=1-183.
DR   PDB; 6M52; EM; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 6M54; EM; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 6WYF; X-ray; 1.25 A; A=2-183.
DR   PDB; 6WYG; X-ray; 2.27 A; A/B/C/D=2-183.
DR   PDB; 6WYH; X-ray; 2.22 A; A/B/C/D=2-183.
DR   PDB; 6Z6U; EM; 1.25 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 6Z9E; EM; 1.55 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 6Z9F; EM; 1.56 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 7A6A; EM; 1.15 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 7A6B; EM; 1.33 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 7CK8; X-ray; 1.80 A; A/B/C/D/E/F/G/H/I/J/K/L=5-177.
DR   PDB; 7CK9; X-ray; 1.60 A; A=6-177.
DR   PDB; 7JGK; X-ray; 2.68 A; A=2-183.
DR   PDB; 7JGL; X-ray; 2.34 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/a/b/c/d/e/f=2-183.
DR   PDB; 7JGM; X-ray; 2.31 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/a/b/c/d/e/f=2-183.
DR   PDB; 7JGN; X-ray; 2.07 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/a/b/c/d/e/f=2-183.
DR   PDB; 7JGO; X-ray; 3.08 A; A=2-183.
DR   PDB; 7JGP; X-ray; 6.42 A; A=2-183.
DR   PDB; 7JGQ; X-ray; 3.01 A; A=2-183.
DR   PDB; 7K26; X-ray; 2.70 A; A/B/C/D/E/F/G/H/I/J/K/L=2-183.
DR   PDB; 7K3V; EM; 1.34 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 7K3W; EM; 1.36 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 7KE3; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 7KE5; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L=2-183.
DR   PDB; 7PF1; EM; 2.10 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=4-177.
DR   PDB; 7R5O; EM; 1.60 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=5-177.
DR   PDB; 7RRP; EM; 1.27 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 7V66; EM; 1.89 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 7VD8; EM; 1.96 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 7ZG7; EM; 1.77 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 8A2L; X-ray; 2.30 A; AAA=2-183.
DR   PDB; 8A2M; X-ray; 1.57 A; AAA=2-183.
DR   PDB; 8A5N; X-ray; 1.52 A; AAA=2-183.
DR   PDB; 8AAV; X-ray; 2.00 A; A/B/C/D/E/F/G/H=2-183.
DR   PDB; 8B7O; X-ray; 1.17 A; AAA=2-183.
DR   PDB; 8CPM; EM; 1.81 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPS; EM; 1.82 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPT; EM; 1.79 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPU; EM; 1.76 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPV; EM; 1.76 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPW; EM; 1.79 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8CPX; EM; 1.76 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=5-177.
DR   PDB; 8DHX; EM; 2.92 A; 1/2/4/6/A/B/E/F/G/H/I/K/M/O/P/Q/S/U/W/X/Y/a/e/r=1-183.
DR   PDB; 8DNP; EM; 2.69 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 8F49; EM; 1.80 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 8F4L; EM; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 8HHS; EM; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=6-177.
DR   PDB; 8J9L; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 8J9M; X-ray; 2.90 A; A/B/C=1-183.
DR   PDB; 8JAI; X-ray; 2.56 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 8KFD; X-ray; 1.80 A; A=2-183.
DR   PDB; 8PP2; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=6-177.
DR   PDB; 8PP3; X-ray; 1.55 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 8PP5; X-ray; 2.00 A; A/B/C/D/E/F=6-177.
DR   PDB; 8QU9; EM; 2.88 A; A=6-183.
DR   PDB; 8W92; X-ray; 2.12 A; A=1-183.
DR   PDB; 8WB3; X-ray; 2.49 A; A=1-183.
DR   PDB; 8WIE; X-ray; 2.30 A; A/B/C/D/E/F=1-177.
DR   PDB; 8WIQ; EM; 2.19 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 8WJF; EM; 2.02 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 8XWB; X-ray; 1.69 A; A=6-177.
DR   PDB; 8Y6F; X-ray; 2.01 A; A/B/C/D/E/F/G/H/I/J/K/L=1-182.
DR   PDB; 9JIU; X-ray; 2.28 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 9JQB; EM; 1.78 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 9JQC; EM; 1.73 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 9JQD; EM; 1.81 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 9JQE; EM; 1.83 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-183.
DR   PDB; 9KAY; EM; 1.73 A; Aa/Ab/Ac/Ad/Ae/Af/Ag/Ah/Ai/Aj/Ak/Al/Am/An/Ao/Ap/Aq/Ar/As/At/Au/Av/Aw/Ax=2-160.
DR   PDBsum; 1FHA; -.
DR   PDBsum; 2CEI; -.
DR   PDBsum; 2CHI; -.
DR   PDBsum; 2CIH; -.
DR   PDBsum; 2CLU; -.
DR   PDBsum; 2CN6; -.
DR   PDBsum; 2CN7; -.
DR   PDBsum; 2FHA; -.
DR   PDBsum; 2IU2; -.
DR   PDBsum; 2Z6M; -.
DR   PDBsum; 3AJO; -.
DR   PDBsum; 3AJP; -.
DR   PDBsum; 3AJQ; -.
DR   PDBsum; 3ERZ; -.
DR   PDBsum; 3ES3; -.
DR   PDBsum; 4DYX; -.
DR   PDBsum; 4DYY; -.
DR   PDBsum; 4DYZ; -.
DR   PDBsum; 4DZ0; -.
DR   PDBsum; 4OYN; -.
DR   PDBsum; 4Y08; -.
DR   PDBsum; 4YKH; -.
DR   PDBsum; 4ZJK; -.
DR   PDBsum; 5CMQ; -.
DR   PDBsum; 5CMR; -.
DR   PDBsum; 5GN8; -.
DR   PDBsum; 5GOU; -.
DR   PDBsum; 5JKK; -.
DR   PDBsum; 5JKL; -.
DR   PDBsum; 5JKM; -.
DR   PDBsum; 5N26; -.
DR   PDBsum; 5N27; -.
DR   PDBsum; 5UP7; -.
DR   PDBsum; 5UP8; -.
DR   PDBsum; 5UP9; -.
DR   PDBsum; 5VTD; -.
DR   PDBsum; 5XB1; -.
DR   PDBsum; 5YI5; -.
DR   PDBsum; 5ZND; -.
DR   PDBsum; 6B8F; -.
DR   PDBsum; 6B8G; -.
DR   PDBsum; 6FTV; -.
DR   PDBsum; 6GSR; -.
DR   PDBsum; 6H5I; -.
DR   PDBsum; 6H6T; -.
DR   PDBsum; 6H6U; -.
DR   PDBsum; 6IPC; -.
DR   PDBsum; 6IPO; -.
DR   PDBsum; 6IPP; -.
DR   PDBsum; 6IPQ; -.
DR   PDBsum; 6J4A; -.
DR   PDBsum; 6J7G; -.
DR   PDBsum; 6JOB; -.
DR   PDBsum; 6JPS; -.
DR   PDBsum; 6KE2; -.
DR   PDBsum; 6KE4; -.
DR   PDBsum; 6M52; -.
DR   PDBsum; 6M54; -.
DR   PDBsum; 6WYF; -.
DR   PDBsum; 6WYG; -.
DR   PDBsum; 6WYH; -.
DR   PDBsum; 6Z6U; -.
DR   PDBsum; 6Z9E; -.
DR   PDBsum; 6Z9F; -.
DR   PDBsum; 7A6A; -.
DR   PDBsum; 7A6B; -.
DR   PDBsum; 7CK8; -.
DR   PDBsum; 7CK9; -.
DR   PDBsum; 7JGK; -.
DR   PDBsum; 7JGL; -.
DR   PDBsum; 7JGM; -.
DR   PDBsum; 7JGN; -.
DR   PDBsum; 7JGO; -.
DR   PDBsum; 7JGP; -.
DR   PDBsum; 7JGQ; -.
DR   PDBsum; 7K26; -.
DR   PDBsum; 7K3V; -.
DR   PDBsum; 7K3W; -.
DR   PDBsum; 7KE3; -.
DR   PDBsum; 7KE5; -.
DR   PDBsum; 7PF1; -.
DR   PDBsum; 7R5O; -.
DR   PDBsum; 7RRP; -.
DR   PDBsum; 7V66; -.
DR   PDBsum; 7VD8; -.
DR   PDBsum; 7ZG7; -.
DR   PDBsum; 8A2L; -.
DR   PDBsum; 8A2M; -.
DR   PDBsum; 8A5N; -.
DR   PDBsum; 8AAV; -.
DR   PDBsum; 8B7O; -.
DR   PDBsum; 8CPM; -.
DR   PDBsum; 8CPS; -.
DR   PDBsum; 8CPT; -.
DR   PDBsum; 8CPU; -.
DR   PDBsum; 8CPV; -.
DR   PDBsum; 8CPW; -.
DR   PDBsum; 8CPX; -.
DR   PDBsum; 8DHX; -.
DR   PDBsum; 8DNP; -.
DR   PDBsum; 8F49; -.
DR   PDBsum; 8F4L; -.
DR   PDBsum; 8HHS; -.
DR   PDBsum; 8J9L; -.
DR   PDBsum; 8J9M; -.
DR   PDBsum; 8JAI; -.
DR   PDBsum; 8KFD; -.
DR   PDBsum; 8PP2; -.
DR   PDBsum; 8PP3; -.
DR   PDBsum; 8PP5; -.
DR   PDBsum; 8QU9; -.
DR   PDBsum; 8W92; -.
DR   PDBsum; 8WB3; -.
DR   PDBsum; 8WIE; -.
DR   PDBsum; 8WIQ; -.
DR   PDBsum; 8WJF; -.
DR   PDBsum; 8XWB; -.
DR   PDBsum; 8Y6F; -.
DR   PDBsum; 9JIU; -.
DR   PDBsum; 9JQB; -.
DR   PDBsum; 9JQC; -.
DR   PDBsum; 9JQD; -.
DR   PDBsum; 9JQE; -.
DR   PDBsum; 9KAY; -.
DR   AlphaFoldDB; P02794; -.
DR   EMDB; EMD-0046; -.
DR   EMDB; EMD-0140; -.
DR   EMDB; EMD-11103; -.
DR   EMDB; EMD-11121; -.
DR   EMDB; EMD-11122; -.
DR   EMDB; EMD-11668; -.
DR   EMDB; EMD-11669; -.
DR   EMDB; EMD-13364; -.
DR   EMDB; EMD-14332; -.
DR   EMDB; EMD-14705; -.
DR   EMDB; EMD-16783; -.
DR   EMDB; EMD-16784; -.
DR   EMDB; EMD-16785; -.
DR   EMDB; EMD-16786; -.
DR   EMDB; EMD-16787; -.
DR   EMDB; EMD-16788; -.
DR   EMDB; EMD-16789; -.
DR   EMDB; EMD-18658; -.
DR   EMDB; EMD-22657; -.
DR   EMDB; EMD-22658; -.
DR   EMDB; EMD-24665; -.
DR   EMDB; EMD-27437; -.
DR   EMDB; EMD-27576; -.
DR   EMDB; EMD-30083; -.
DR   EMDB; EMD-30084; -.
DR   EMDB; EMD-31736; -.
DR   EMDB; EMD-31910; -.
DR   EMDB; EMD-37566; -.
DR   EMDB; EMD-37578; -.
DR   EMDB; EMD-3853; -.
DR   EMDB; EMD-3854; -.
DR   EMDB; EMD-61726; -.
DR   EMDB; EMD-61727; -.
DR   EMDB; EMD-61728; -.
DR   EMDB; EMD-61729; -.
DR   EMDB; EMD-62216; -.
DR   EMDB; EMD-6714; -.
DR   EMDB; EMD-6830; -.
DR   SMR; P02794; -.
DR   BioGRID; 108773; 176.
DR   CORUM; P02794; -.
DR   DIP; DIP-38301N; -.
DR   FunCoup; P02794; 167.
DR   IntAct; P02794; 136.
DR   MINT; P02794; -.
DR   STRING; 9606.ENSP00000273550; -.
DR   DrugBank; DB13995; Ferric pyrophosphate citrate.
DR   DrugBank; DB14490; Ferrous ascorbate.
DR   DrugBank; DB14491; Ferrous fumarate.
DR   DrugBank; DB14488; Ferrous gluconate.
DR   DrugBank; DB14501; Ferrous glycine sulfate.
DR   DrugBank; DB14489; Ferrous succinate.
DR   DrugBank; DB06784; Gallium citrate Ga-67.
DR   DrugBank; DB01592; Iron.
DR   DrugBank; DB00893; Iron Dextran.
DR   GlyGen; P02794; 3 sites, 2 N-linked glycans (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; P02794; -.
DR   PhosphoSitePlus; P02794; -.
DR   SwissPalm; P02794; -.
DR   BioMuta; FTH1; -.
DR   DMDM; 120516; -.
DR   jPOST; P02794; -.
DR   MassIVE; P02794; -.
DR   PaxDb; 9606-ENSP00000273550; -.
DR   PeptideAtlas; P02794; -.
DR   ProteomicsDB; 51600; -.
DR   Pumba; P02794; -.
DR   TopDownProteomics; P02794; -.
DR   ABCD; P02794; 5 sequenced antibodies.
DR   Antibodypedia; 28385; 884 antibodies from 41 providers.
DR   DNASU; 2495; -.
DR   Ensembl; ENST00000273550.12; ENSP00000273550.7; ENSG00000167996.16.
DR   Ensembl; ENST00000620041.5; ENSP00000484477.1; ENSG00000167996.16.
DR   GeneID; 2495; -.
DR   KEGG; hsa:2495; -.
DR   MANE-Select; ENST00000273550.12; ENSP00000273550.7; NM_002032.3; NP_002023.2.
DR   UCSC; uc001nsu.3; human.
DR   AGR; HGNC:3976; -.
DR   CTD; 2495; -.
DR   DisGeNET; 2495; -.
DR   GeneCards; FTH1; -.
DR   HGNC; HGNC:3976; FTH1.
DR   HPA; ENSG00000167996; Low tissue specificity.
DR   MalaCards; FTH1; -.
DR   MIM; 134770; gene.
DR   MIM; 615517; phenotype.
DR   MIM; 620669; phenotype.
DR   OpenTargets; ENSG00000167996; -.
DR   Orphanet; 247790; FTH1-related iron overload.
DR   VEuPathDB; HostDB:ENSG00000167996; -.
DR   eggNOG; KOG2332; Eukaryota.
DR   GeneTree; ENSGT00950000182841; -.
DR   HOGENOM; CLU_065681_4_0_1; -.
DR   InParanoid; P02794; -.
DR   OMA; FFLKASM; -.
DR   OrthoDB; 186462at2759; -.
DR   PAN-GO; P02794; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; P02794; -.
DR   BRENDA; 1.16.3.1; 2681.
DR   PathwayCommons; P02794; -.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   SignaLink; P02794; -.
DR   SIGNOR; P02794; -.
DR   BioGRID-ORCS; 2495; 81 hits in 1125 CRISPR screens.
DR   CD-CODE; ECAD3DEA; Ferritin -NCOA4 condensate.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; FTH1; human.
DR   EvolutionaryTrace; P02794; -.
DR   GeneWiki; FTH1; -.
DR   GenomeRNAi; 2495; -.
DR   Pharos; P02794; Tbio.
DR   PRO; PR:P02794; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P02794; protein.
DR   Bgee; ENSG00000167996; Expressed in stromal cell of endometrium and 198 other cell types or tissues.
DR   ExpressionAtlas; P02794; baseline and differential.
DR   GO; GO:0044754; C:autolysosome; IDA:MGI.
DR   GO; GO:0005776; C:autophagosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0070288; C:ferritin complex; TAS:ProtInc.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0008199; F:ferric iron binding; IBA:GO_Central.
DR   GO; GO:0008198; F:ferrous iron binding; IMP:UniProtKB.
DR   GO; GO:0004322; F:ferroxidase activity; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005506; F:iron ion binding; TAS:ProtInc.
DR   GO; GO:0140315; F:iron ion sequestering activity; IDA:GO_Central.
DR   GO; GO:0006955; P:immune response; ISS:UniProtKB.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; TAS:ProtInc.
DR   GO; GO:0006826; P:iron ion transport; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0110076; P:negative regulation of ferroptosis; IMP:UniProtKB.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB.
DR   CDD; cd01056; Euk_Ferritin; 1.
DR   FunFam; 1.20.1260.10:FF:000024; Ferritin heavy chain; 1.
DR   Gene3D; 1.20.1260.10; -; 1.
DR   InterPro; IPR001519; Ferritin.
DR   InterPro; IPR012347; Ferritin-like.
DR   InterPro; IPR009040; Ferritin-like_diiron.
DR   InterPro; IPR009078; Ferritin-like_SF.
DR   InterPro; IPR014034; Ferritin_CS.
DR   InterPro; IPR008331; Ferritin_DPS_dom.
DR   PANTHER; PTHR11431; FERRITIN; 1.
DR   PANTHER; PTHR11431:SF37; FERRITIN HEAVY CHAIN; 1.
DR   Pfam; PF00210; Ferritin; 1.
DR   SUPFAM; SSF47240; Ferritin-like; 1.
DR   PROSITE; PS00540; FERRITIN_1; 1.
DR   PROSITE; PS00204; FERRITIN_2; 1.
DR   PROSITE; PS50905; FERRITIN_LIKE; 1.
DR   neXtProt; NX_P02794; -.
DR   PharmGKB; PA28392; -.
DR   TreeFam; TF313885; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Cytoplasmic vesicle; Iron;
KW   Iron storage; Lysosome; Metal-binding; Neurodegeneration; Oxidoreductase;
KW   Phosphoprotein; Proteomics identification; Reference proteome.
FT   CHAIN           1..183
FT                   /note="Ferritin heavy chain"
FT                   /id="PRO_0000201048"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..183
FT                   /note="Ferritin heavy chain, N-terminally processed"
FT                   /id="PRO_0000424472"
FT   DOMAIN          11..160
FT                   /note="Ferritin-like diiron"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00085"
FT   BINDING         28
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:1992356,
FT                   ECO:0007744|PDB:1FHA"
FT   BINDING         63
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:1992356,
FT                   ECO:0007744|PDB:1FHA"
FT   BINDING         63
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00085"
FT   BINDING         66
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:1992356,
FT                   ECO:0007744|PDB:1FHA"
FT   BINDING         108
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00085"
FT   BINDING         142
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00085"
FT   SITE            23
FT                   /note="Essential for association with cargo receptor NCOA4"
FT                   /evidence="ECO:0000269|PubMed:26436293"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine; in Ferritin heavy chain, N-
FT                   terminally processed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18318008"
FT   MUTAGEN         23
FT                   /note="R->A: Abrogates interaction with NCOA4. Fails to
FT                   localize to punctate lysosomal structures."
FT                   /evidence="ECO:0000269|PubMed:26436293"
FT   MUTAGEN         28
FT                   /note="E->A: Reduces iron binding and oxidation rate; when
FT                   associated with Q-87."
FT                   /evidence="ECO:0000269|PubMed:9003196"
FT   MUTAGEN         87
FT                   /note="K->Q: Reduces iron binding and oxidation rate; when
FT                   associated with A-28. No effect on iron binding but the
FT                   oxidation rate is severely reduced; when associated with
FT                   A-108."
FT                   /evidence="ECO:0000269|PubMed:9003196"
FT   MUTAGEN         108
FT                   /note="E->A: No effect on iron binding but the oxidation
FT                   rate is severely reduced; when associated with Q-87."
FT                   /evidence="ECO:0000269|PubMed:9003196"
FT   CONFLICT        176..183
FT                   /note="LGDSDNES -> WETVIMKAKPRANFP (in Ref. 1; CAA25086)"
FT                   /evidence="ECO:0000305"
FT   HELIX           15..42
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   TURN            45..47
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   HELIX           50..77
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   HELIX           97..124
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   HELIX           128..137
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   HELIX           139..159
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   TURN            160..163
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   HELIX           165..174
FT                   /evidence="ECO:0007829|PDB:6B8F"
FT   STRAND          176..178
FT                   /evidence="ECO:0007829|PDB:5UP8"
SQ   SEQUENCE   183 AA;  21226 MW;  FEF75640A29CCF56 CRC64;
     MTTASTSQVR QNYHQDSEAA INRQINLELY ASYVYLSMSY YFDRDDVALK NFAKYFLHQS
     HEEREHAEKL MKLQNQRGGR IFLQDIKKPD CDDWESGLNA MECALHLEKN VNQSLLELHK
     LATDKNDPHL CDFIETHYLN EQVKAIKELG DHVTNLRKMG APESGLAEYL FDKHTLGDSD
     NES
//
